Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Diabetes-induced bradycardia is an intrinsic metabolic defect reversed by carnitine.

Authors:
Michael A Malone Douglas D Schocken Suzan K Hanna Xiaomei Liang John I Malone

Metabolism 2007 Aug;56(8):1118-23

Julia Parrish Diabetes Research Institute, University of South Florida College of Medicine, Tampa, FL 33612-4742, USA.

Rats with streptozotocin-induced diabetes (STZ-D) have reduced serum carnitine levels and bradycardia. Heart rates (HRs) of 24nondiabetic rats (NRs) and 24 STZ-D rats were compared. L-carnitine (C) was added to the drinking water of rats (12 STZ-D+C) to raise their serum carnitine level. The intrinsic HR for each animal was determined after parasympathetic and sympathetic blockade. The HRs of STZ-D rats (278+/-15 beats per minute) were less than those of NRs (348+/-8 beats per minute) (P<.01). STZ-D rats had low serum carnitine compared with control and STZ-D+C rats. The difference in HR of STZ-D rats and NRs continued after blockade, indicating that the bradycardia ofdiabetes is intrinsic to the heart. The metabolic milieu reflected in the rats' urinary organic acid profiles differed between the control and STZ-D rats. The HR of STZ-D+C rats (326+/-5 beats per minute) did not differ from those of NRs. Increasing either the insulin dose or the serum free carnitine reduced urinary organic acids, but normal HRs were associated only with elevated serum carnitine levels. When glucose is compromised as a myocardial energy source (diabetes mellitus), we propose that elevated levels of serum carnitine may increase myocardial fatty acid metabolism sufficiently to correct the bradycardia of STZ-D rats.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.metabol.2007.04.005DOI Listing
August 2007

Publication Analysis

Top Keywords

serum carnitine
8
stz-d rats
8
beats minute
8
rats
5
stz-d+c raise
4
drinking water
4
rats stz-d+c
4
water rats
4
l-carnitine drinking
4
rats compared
4
hrs 24nondiabetic
4
rates hrs
4
24nondiabetic rats
4
rats nrs
4
raise serum
4
compared l-carnitine
4
level intrinsic
4
rats 278+/-15
4
hrs stz-d
4
278+/-15 beats
4

Keyword Occurance

Similar Publications

[Clinical features and gene mutations of 6 patients with carnitine palmitoyltransferase 1A deficiency].

Authors:
Y Yu L H Shen W J Qiu H W Zhang J Ye L L Liang Y Wang W J Ji X F Gu L S Han

Zhonghua Yi Xue Za Zhi 2021 Apr;101(14):1041-1044

Department of Pediatric Endocrinology and Genetic Metabolism, Shanghai Xinhua Children's Hospital, Shanghai Institute for Pediatric Research, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China.

The clinical and biochemical data and gene sequencing results of patients with carnitine palmitoyltransferase 1A deficiency were analyzed, in order to improve the understanding of the disease. Six patients (5 males and 1 female, aged from 1 to 8 years old) with carnitine palmitoyltransferase 1A deficiency from Department of Pediatric Endocrinology and Genetic Metabolism, Xinhua Hospital between 2008 and 2019 were included. Two cases were detected by neonatal screening and had no clinical symptoms. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Effect of l-carnitine on cardiotoxicity and apoptosis induced by imatinib through PDGF/ PPARγ /MAPK pathways.

Authors:
Heba H Mansour Shereen M El Kiki Amel B Ibrahim Mervat M Omran

Arch Biochem Biophys 2021 Apr 9:108866. Epub 2021 Apr 9.

Pharmacology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Egypt. Electronic address:

A tyrosine kinase inhibitor Imatinib (IM) is used in the treatment of different varieties of cancers. The current study was designed to explore the beneficial role of l-carnitine against IM-induced cardiotoxicity in rats. Male albino rats received IM (40 mg/kg, i. Read More

View Article and Full-Text PDF
April 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap